Zobrazeno 1 - 10
of 131
pro vyhledávání: '"D, Hönack"'
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 279(2)
We have reported recently that the seizure model and experimental protocol may markedly influence anticonvulsant tolerance and withdrawal characteristics of benzodiazepine (BDZ) receptor ligands so that predictions on tolerance and dependence liabili
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c952e11e1a1e3b2453322e4bb517b300
https://pubmed.ncbi.nlm.nih.gov/8930158
https://pubmed.ncbi.nlm.nih.gov/8930158
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 279(2)
We have reported recently that seizure model and experimental protocol may influence the anticonvulsant tolerance and the withdrawal characteristics of benzodiazepine (BDZ) receptor ligands so that predictions on tolerance and dependence liability of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f9bc672f6ac9ed2b295847e89d9e2846
https://pubmed.ncbi.nlm.nih.gov/8930159
https://pubmed.ncbi.nlm.nih.gov/8930159
Publikováno v:
Advances in experimental medicine and biology. 398
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fda087e8d56cf74c5de01196188c11ac
https://pubmed.ncbi.nlm.nih.gov/8906275
https://pubmed.ncbi.nlm.nih.gov/8906275
Publikováno v:
Advances in Experimental Medicine and Biology ISBN: 9781461380269
The brain metabolite kynurenic acid (KYNA, Moroni et al., 1988 J.Neurochem. 51, 177), is a broad spectrum antagonist of excitatory amino acid receptors, can antagonize the strychnine-insensitive glycine site associated with the N-methyl-D-aspartate r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::233c0f7150d11a3ef60eb764bb35dc48
https://doi.org/10.1007/978-1-4613-0381-7_41
https://doi.org/10.1007/978-1-4613-0381-7_41
Autor:
W, Löscher, D, Hönack
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 274(1)
L-Deprenyl (selegiline) is an irreversible inhibitor of monoamine oxidase type B, but also exerts several effects on dopamine and noradrenaline systems independent of monoamine oxidase type B inhibition. Thanks to these properties, L-deprenyl has gai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5d2add2d6b5ee7877c4e12cb28353045
https://pubmed.ncbi.nlm.nih.gov/7616414
https://pubmed.ncbi.nlm.nih.gov/7616414
Publikováno v:
Brain research. 620(1)
The behavioural effects of the N-methyl-D-aspartate (NMDA) receptor antagonist MK-801 (dizocilpine) were compared in age-matched female and male Wistar rats. At a dose of 0.1 mg/kg i.p., almost no behavioural alterations were seen in male rats, while
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f4dac8afa490136d895e34c4163e20a
https://pubmed.ncbi.nlm.nih.gov/8402193
https://pubmed.ncbi.nlm.nih.gov/8402193
Autor:
W, Löscher, D, Hönack
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 257(3)
The novel competitive N-methyl-D-aspartate (NMDA) receptor antagonist DL-(E)-2-amino-4-methyl-5-phosphono-3-pentenoic acid (CGP 37849) was found to produce a phencyclidine (PCP)-like behavioral syndrome (ataxia, locomotion, stereotypies) in amygdala-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d17950f8e4643603830da44132a16974
https://pubmed.ncbi.nlm.nih.gov/1675288
https://pubmed.ncbi.nlm.nih.gov/1675288
Publikováno v:
Neuroscience letters. 124(1)
The effects of the non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist MK-801 and the novel competitive NMDA receptor antagonist CGP 39551 on levels of 11 amino acids, including several excitatory and inhibitory neurotransmitters, were st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::375a8e987203d9b70499a9012c25b27b
https://pubmed.ncbi.nlm.nih.gov/1677457
https://pubmed.ncbi.nlm.nih.gov/1677457
Autor:
W, Löscher, D, Hönack
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 256(2)
The orally active competitive N-methyl-D-aspartate (NMDA) receptor antagonists CGP 37849 (DL-[E]-2-amino-4-methyl-5-phosphono-3-pentenoic acid) and its ethyl ester CGP 39551 were evaluated in amygdala-kindled rats, a model for complex partial and sec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8fd97fa00070f4f089aa772dc92bad72
https://pubmed.ncbi.nlm.nih.gov/1671593
https://pubmed.ncbi.nlm.nih.gov/1671593
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 255(2)
Abecarnil (ZK 112119; isopropyl-6-benzyloxy-4-methoxymethyl-beta-carboline-3-carboxylate), a novel beta-carboline with high affinity for central benzodiazepine (BZ) receptors, has been shown recently to be a potent anxiolytic and anticonvulsant in an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::06240f270160e84cdd171b84f4e06aa4
https://pubmed.ncbi.nlm.nih.gov/1978730
https://pubmed.ncbi.nlm.nih.gov/1978730